The Week in Health: The US vs VAPE Inc.By Jan Hogewoning | Fri, 11/22/2019 - 13:10
Authorities are closing in on what was once deemed as the product that would kill the cigarette. Will the government spare this imperfect alternative or are they stopping a pen of destruction?
Meanwhile, promising results are posted by scientists around the world, including a development that could resolve a long-running feminist topic: sexism in contraception.
The WHO issues worrying statements that numb optimism and call for immediate action. In Mexico, IMSS looks to brighten the room with a theatre tour.
Ready for your weekly dose? Here’s the roundup:
Vaping and E-cigarettes
Massachusetts moves towards a full ban on flavored tobacco and vaping products.
New York joins California in a case against Juul, the largest manufacturer of vapers in the US.
New Progress in Medicine
The Indian Council of Medical Research announces the first contraceptive for men, which will be administered through injection.
Researchers at King’s College London and Taichung University of Chinese Medicine report that they have found Omega-3 fish oil as effective in treating ADHD in children as regular ADHD medication.
AstraZeneca sees shares rise as its leukemia drug sees an early US approval.
Purdue Pharma is accused of publishing false statements about OxyContin that could mislead the public.
From the WHO
According to WHO, 80 percent of adolescents worldwide do not meet the minimum exercise recommendation issued by the organization.
Meanwhile in Mexico
The Mexican Society of Pneumology and Surgery of the Thorax has presented a Mexican guide to chronic obstructive pulmonary disease (COPD) on World COPD day.
IMSS has launched its first theatre tour with the play Felipe Ángeles,written by Elena Garro.